The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
FoxO1 mediates insulin-dependent regulation of hepatic VLDL production in mice
Open accessAbstract
Excessive production of triglyceride-rich VLDL is attributable to hypertriglyceridemia. VLDL production is facilitated by microsomal triglyceride transfer protein (MTP) in a rate-limiting step that is regulated by insulin. To characterize the underlying mechanism, we studied hepatic MTP regulation by forkhead box O1 (FoxO1), a transcription factor that plays a key role in hepatic insulin signaling. In HepG2 cells, MTP expression was induced by FoxO1 and inhibited by exposure to insulin. This effect correlated with the ability of FoxO1 to bind and stimulate MTP promoter activity. Deletion or mutation of the FoxO1 target site within the MTP promoter disabled FoxO1 binding and resulted in abolition of insulin-dependent regulation of MTP expression. We generated mice that expressed a constitutively active FoxO1 transgene and found that increased FoxO1 activity was associated with enhanced MTP expression, augmented VLDL production, and elevated plasma triglyceride levels. In contrast, RNAi-mediated silencing of hepatic FoxO1 was associated with reduced MTP and VLDL production in adult mice. Furthermore, we found that hepatic FoxO1 abundance and MTP production were increased in mice with abnormal triglyceride metabolism. These data suggest that FoxO1 mediates insulin regulation of MTP production and that augmented MTP levels may be a causative factor for VLDL overproduction and hypertriglyceridemia in diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2004) · doi:10.1016/s0092-8674(04)00452-0 · Cited by 1,356
Hepatocyte-specific Pten deficiency results in steatohepatitis and hepatocellular carcinomas
Horie, Y., Suzuki, A., Kataoka, E., Sasaki, T., Hamada, K., Sasaki, J., Mizuno, K., Hasegawa, G., Kishimoto, H., Iizuka, M., et al. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200420513 · Cited by 698
Metabolic Syndrome: A Clinical and Molecular Perspective
Moller, D. E., & Kaufman, K. D. (2005) · Annual Review of Medicine · doi:10.1146/annurev.med.56.082103.104751 · Cited by 631
Hyperlipidemic Effects of Dietary Saturated Fats Mediated through PGC-1β Coactivation of SREBP
Lin, J., Yang, R., Tarr, P. T., Wu, P.-H., Handschin, C., Li, S., Yang, W., Pei, L., Uldry, M., Tontonoz, P., et al. (2005) · Cell · doi:10.1016/j.cell.2004.11.043 · Cited by 625
Nakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Matsumoto, M., Pocai, A., Rossetti, L., DePinho, R. A., & Accili, D. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.006 · Cited by 615
FoxO proteins in insulin action and metabolism
Barthel, A., Schmoll, D., & Unterman, T. G. (2005) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2005.03.010 · Cited by 604
Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly
Hussain, M. M., Shi, J., & Dreizen, P. (2003) · Journal of Lipid Research · doi:10.1194/jlr.r200014-jlr200 · Cited by 591
Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia
Cuchel, M., Bloedon, L. T., Szapary, P. O., Kolansky, D. M., Wolfe, M. L., Sarkis, A., Millar, J. S., Ikewaki, K., Siegelman, E. S., Gregg, R. E., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa061189 · Cited by 580
Molecular Mechanisms Regulating Hormone-Sensitive Lipase and Lipolysis
Holm, C., Østerlund, T., Laurell, H., & Contreras, J. A. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.365 · Cited by 564
Regulation of Plasma Triglycerides in Insulin Resistance and Diabetes
Ginsberg, H. N., Zhang, Y.-L., & Hernandez-Ono, A. (2005) · Archives of Medical Research · doi:10.1016/j.arcmed.2005.01.005 · Cited by 531
FoxO1 Regulates Multiple Metabolic Pathways in the Liver
Zhang, W., Patil, S., Chauhan, B., Guo, S., Powell, D. R., Le, J., Klotsas, A., Matika, R., Xiao, X., Franks, R., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600272200 · Cited by 516
The Foxa family of transcription factors in development and metabolism
Friedman, J. R., & Kaestner, K. H. (2006) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-006-6095-6 · Cited by 515
Lewis, G. F., Uffelman, K. D., Szeto, L. W., Weller, B., & Steiner, G. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117633 · Cited by 502
Nakae, J., Park, B.-C., & Accili, D. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.23.15982 · Cited by 470
Biddinger, S. B., Hernandez-Ono, A., Rask-Madsen, C., Haas, J. T., Alemán, J. O., Suzuki, R., Scapa, E. F., Agarwal, C., Carey, M. C., Stephanopoulos, G., et al. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.013 · Cited by 469
Stiles, B., Wang, Y., Stahl, A., Bassilian, S., Lee, W. P., Kim, Y.-J., Sherwin, R., Devaskar, S., Lesche, R., Magnuson, M. A., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0308617100 · Cited by 436
Matsumoto, M. (2006) · Journal of Clinical Investigation · doi:10.1172/jci27047 · Cited by 436
Foxa2 regulates lipid metabolism and ketogenesis in the liver during fasting and in diabetes
Wolfrum, C., Asilmaz, E., Luca, E., Friedman, J. M., & Stoffel, M. (2004) · Nature · doi:10.1038/nature03047 · Cited by 430
Pullinger, C. R., North, J. D., Teng, B. B., Rifici, V. A., Ronhild de Brito, A. E., & Scott, J. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38287-0 · Cited by 412
Raabe, M., Véniant, M. M., Sullivan, M. A., Zlot, C. H., Björkegren, J., Nielsen, L. B., Wong, J. S., Hamilton, R. L., & Young, S. G. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6576 · Cited by 395
Bernal-Mizrachi, E., Wen, W., Stahlhut, S., Welling, C. M., & Permutt, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13785 · Cited by 382
Essentiality of circulating fatty acids for glucose-stimulated insulin secretion in the fasted rat.
Stein, D. T., Esser, V, Stevenson, B. E., Lane, K. E., Whiteside, J. H., Daniels, M. B., Chen, S., & McGarry, J. D. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118727 · Cited by 378
Ota, T., Gayet, C., & Ginsberg, H. N. (2008) · Journal of Clinical Investigation · doi:10.1172/jci32752 · Cited by 376
Bernal-Mizrachi, E., Wen, W., Stahlhut, S., Welling, C. M., & Permutt, M. A. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200113785 · Cited by 332
Lipid and lipoprotein dysregulation in insulin resistant states
Avramoglu, R. K., Basciano, H., & Adeli, K. (2006) · Clinica Chimica Acta · doi:10.1016/j.cca.2005.12.026 · Cited by 318
The Role of the Microsomal Triglygeride Transfer Protein in Abetalipoproteinemia
Berriot-Varoqueaux, N., Aggerbeck, L. P., Samson-Bouma, M.-E., & Wetterau, J. R. (2000) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.20.1.663 · Cited by 312
Foxo1 mediates insulin action on apoC-III and triglyceride metabolism
Altomonte, J., Lin, C., Harbaran, S., Richter, A. M., Xu, J., Meseck, M. L., & Dong, H. H. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19992 · Cited by 309
Self-citationFatty acid regulation of very low density lipoprotein production
Lewis, G. F. (1997) · Current Opinion in Lipidology · doi:10.1097/00041433-199706000-00004 · Cited by 294
Hall, R. K., Yamasaki, T., Kucera, T., Waltner-Law, M., O'Brien, R., & Granner, D. K. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m004898200 · Cited by 284
Nakae, J., Barr, V., & Accili, D. (2000) · The EMBO Journal · doi:10.1093/emboj/19.5.989 · Cited by 267
New Perspectives on Atherogenesis: Role of Abnormal Triglyceride-Rich Lipoprotein Metabolism
Ginsberg, H. N. (2002) · Circulation · doi:10.1161/01.cir.0000035280.64322.31 · Cited by 255
Insulin modulation of hepatic synthesis and secretion of apolipoprotein B by rat hepatocytes.
Sparks, J. D., & Sparks, C. E. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38966-5 · Cited by 253
Inhibition of Foxo1 function is associated with improved fasting glycemia in diabetic mice
Altomonte, J., Richter, A., Harbaran, S., Suriawinata, J., Nakae, J., Thung, S. N., Meseck, M., Accili, D., & Dong, H. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00156.2003 · Cited by 227
Self-citationO'Brien, R. M., Noisin, E. L., Suwanichkul, A., Yamasaki, T., Lucas, P. C., Wang, J.-C., Powell, D. R., & Granner, D. K. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.3.1747 · Cited by 226
Regulation of Phosphatidylinositol 3′-Kinase by Tyrosyl Phosphoproteins
Rordorf-Nikolic, T., Van Horn, D. J., Chen, D., White, M. F., & Backer, J. M. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.8.3662 · Cited by 225
Durrington, P. N., Newton, R. S., Weinstein, D. B., & Steinberg, D. (1982) · Journal of Clinical Investigation · doi:10.1172/jci110604 · Cited by 215
Effects of insulin and acipimox on VLDL1 and VLDL2 apolipoprotein B production in normal subjects.
Malmström, R., Packard, C. J., Caslake, M., Bedford, D., Stewart, P., Yki-Järvinen, H., Shepherd, J., & Taskinen, M. R. (1998) · Diabetes · doi:10.2337/diabetes.47.5.779 · Cited by 198
Lin, M. C., Gordon, D., & Wetterau, J. R. (1995) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)39865-5 · Cited by 198
Insulin-regulated gene expression
O'Brien, R. M., Streeper, R. S., Ayala, J. E., Stadelmaier, B. T., & Hornbuckle, L. A. (2001) · Biochemical Society Transactions · doi:10.1042/bst0290552 · Cited by 194
Increased Expression and Activity of the Transcription Factor FOXO1 in Nonalcoholic Steatohepatitis
Valenti, L., Rametta, R., Dongiovanni, P., Maggioni, M., Ludovica Fracanzani, A., Zappa, M., Lattuada, E., Roviaro, G., & Fargion, S. (2008) · Diabetes · doi:10.2337/db07-0714 · Cited by 187
Foxa2 integrates the transcriptional response of the hepatocyte to fasting
Zhang, L., Rubins, N. E., Ahima, R. S., Greenbaum, L. E., & Kaestner, K. H. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.07.002 · Cited by 177
Metabolic Basis of Hypotriglyceridemic Effects of Insulin in Normal Men
Malmström, R., Packard, C. J., Watson, T. D. G., Rannikko, S., Caslake, M., Bedford, D., Stewart, P., Yki-Järvinen, H., Shepherd, J., & Taskinen, M.-R. (1997) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.17.7.1454 · Cited by 177
Role of insulin in lipoprotein secretion by cultured rat hepatocytes.
Patsch, W., Franz, S., & Schonfeld, G. (1983) · Journal of Clinical Investigation · doi:10.1172/jci110865 · Cited by 172
YMXM motifs of IRS-1 define substrate specificity of the insulin receptor kinase.
Shoelson, S. E., Chatterjee, S., Chaudhuri, M., & White, M. F. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.6.2027 · Cited by 169
Wolfrum, C., & Stoffel, M. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.01.001 · Cited by 166
Genes or environment to determine alcoholic liver disease and non‐alcoholic fatty liver disease
Day, C. P. (2006) · Liver International · doi:10.1111/j.1478-3231.2006.01323.x · Cited by 162
Tietge, U. J. F., Bakillah, A., Maugeais, C., Tsukamoto, K., Hussain, M., & Rader, D. J. (1999) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)32437-8 · Cited by 162
Dashti, N., Williams, D. L., & Alaupovic, P. (1989) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38268-7 · Cited by 154
Borradaile, N. M., de Dreu, L. E., & Huff, M. W. (2003) · Diabetes · doi:10.2337/diabetes.52.10.2554 · Cited by 148
Améen, C., Edvardsson, U., Ljungberg, A., Asp, L., Åkerblad, P., Tuneld, A., Olofsson, S., Lindén, D., & Oscarsson, J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m412107200 · Cited by 146
Hagan, D. L., Kienzle, B. K., Jamil, H., & Hariharan, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)61967-8 · Cited by 137
Aberrant Forkhead Box O1 Function Is Associated with Impaired Hepatic Metabolism
Qu, S., Altomonte, J., Perdomo, G., He, J., Fan, Y., Kamagaté, A., Meseck, M. L., & Dong, H. H. (2006) · Endocrinology · doi:10.1210/en.2006-0541 · Cited by 132
Self-citationAllister, E. M., Borradaile, N. M., Edwards, J. Y., & Huff, M. W. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1676 · Cited by 128
PPARα mediates the hypolipidemic action of fibrates by antagonizing FoxO1
Qu, S., Su, D., Altomonte, J., Kamagaté, A., He, J., Perdomo, G., Tse, T. E., Jiang, Y., & Dong, H. H. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00157.2006 · Cited by 121
Self-citationBartels, E. D., Lauritsen, M. L., & Nielsen, L. B. (2002) · Diabetes · doi:10.2337/diabetes.51.4.1233 · Cited by 120
Roux, J. M., PICTET, R. L., & Grange, T. (1995) · DNA and Cell Biology · doi:10.1089/dna.1995.14.385 · Cited by 117
Liao, W., Hui, T. Y., Young, S. G., & Davis, R. A. (2003) · Journal of Lipid Research · doi:10.1194/jlr.m300020-jlr200 · Cited by 117
Sparks, C. E., Sparks, J. D., Bolognino, M., Salhanick, A. I., Strumph, P., & Amatruda, J. M. (1986) · Metabolism · doi:10.1016/0026-0495(86)90026-0 · Cited by 114
Arden, K. C. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00213-8 · Cited by 113
Regulation of Microsomal Triglyceride Transfer Protein Gene by Insulin in HepG2 Cells
Au, W.-S., Kung, H.-F., & Lin, M. C.-M. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1073 · Cited by 108
Wang, J.-C., Strömstedt, P. E., O’Brien, R. M., & Granner, D. K. (1996) · Molecular Endocrinology · doi:10.1210/mend.10.7.8813720 · Cited by 106
Treatment for patients with the metabolic syndrome
Ginsberg, H. N. (2003) · The American Journal of Cardiology · doi:10.1016/s0002-9149(02)03386-6 · Cited by 105
Wiegman, C., Bandsma, R., Ouwens, D. M., van der Sluijs, F. H., Havinga, R., Boer, T. S., Reijngoud, D., Romijn, J. A., & Kuipers, F. (2003) · Diabetes · doi:10.2337/diabetes.52.5.1081 · Cited by 102
Zhang, Y., Hernández‐Ono, A., Ko, C., Yasunaga, K., Huang, L., & Ginsberg, H. N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m400220200 · Cited by 97
Chirieac, D. V., Chirieac, L. R., Corsetti, J. P., Cianci, J., Sparks, C. E., & Sparks, J. D. (2000) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.2000.279.5.e1003 · Cited by 87
Siri, P. W., Candela, N. M., Zhang, Y., Ko, C., Eusufzai, S., Ginsberg, H. N., & Huang, L. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m108909200 · Cited by 79
Nakae, J., Kitamura, T., Ogawa, W., Kasuga, M., & Accili, D. (2001) · Biochemistry · doi:10.1021/bi015532m · Cited by 78
Björkegren, J., Beigneux, A. P., Bergö, M. O., Maher, J. J., & Young, S. G. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m108514200 · Cited by 75
A Deficiency of Microsomal Triglyceride Transfer Protein Reduces Apolipoprotein B Secretion
Leung, G. K. C., Véniant, M. M., Kim, S. K., Zlot, C. H., Raabe, M., Björkegren, J., Neese, R. A., Hellerstein, M. K., & Young, S. G. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.11.7515 · Cited by 70
Apolipoprotein B-containing Lipoprotein Particle Assembly
Manchekar, M., Richardson, P. E., Forte, T. M., Datta, G., Segrest, J. P., & Dashti, N. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m406302200 · Cited by 63
Garcia, P., Shoelson, S. E., George, S. T., Hinds, D. A., GOLDBERG, A. R., & Miller, W. T. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)74581-5 · Cited by 58
Phillips, C. M., Owens, D., Collins, P. B., & TOMKIN, G. H. (2002) · Atherosclerosis · doi:10.1016/s0021-9150(01)00721-3 · Cited by 52
Rao, P., Roccisana, J., Takane, K. K., Bottino, R., Zhao, A. Z., Trucco, M., & García-Ocaña, A. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1664 · Cited by 50
Hyperinsulinemia and Triglyceride-Rich Lipoproteins
Steiner, G. A., & Lewis, G. F. (1996) · Diabetes · doi:10.2337/diab.45.3.s24 · Cited by 44
Sparks, J. D., Sparks, C. E., & Miller, L. L. (1989) · Biochemical Journal · doi:10.1042/bj2610083 · Cited by 38
Hepatic Regulation of Apolipoprotein B
Avramoglu, R. K., & Adeli, K. (2004) · Reviews in Endocrine and Metabolic Disorders · doi:10.1023/b:remd.0000045100.66675.92 · Cited by 37
Microsomal triglyceride transfer protein expression in mouse intestine
Swift, L. L., Jovanovska, A., Kakkad, B., & Ong, D. E. (2005) · Histochemistry and Cell Biology · doi:10.1007/s00418-005-0772-7 · Cited by 37
den Boer, M. A. M., Voshol, P. J., Kuipers, F., Romijn, J. A., & Havekes, L. M. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00188.2006 · Cited by 35
Multiple proteins bind the insulin response element in the human IGFBP-1 promoter
Powell, D. R., Allander, S. V., Scheimann, A. O., Wasserman, R. M., Durham, S. K., & Suwanichkul, A. (1995) · Progress in Growth Factor Research · doi:10.1016/0955-2235(95)00034-8 · Cited by 27
Cited by
Pathophysiology of diabetic dyslipidaemia: where are we?
Vergès, B. (2015) · Diabetologia · doi:10.1007/s00125-015-3525-8 · Cited by 708
Begriche, K., Massart, J., Robin, M.-A., Borgne-Sanchez, A., & Fromenty, B. (2011) · Journal of Hepatology · doi:10.1016/j.jhep.2010.11.006 · Cited by 555
The Role of Metabolic Disorders in Alzheimer Disease and Vascular Dementia: Two Roads Converged
Craft, S. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.27 · Cited by 547
“Acute inhibitory effects of insulin on lipid production are essential for rapid hepatic adaptation to metabolic shifts between fasting and refeeding to maintain plasma lipids within an optimal physiologic range.(29) Thus, insulin resistant adults have higher and more prolonged postprandial excursions of very–lowdensit…”
BackgroundThe role of FoxO in the regulation of metabolism
Gross, D. N., van den Heuvel, A. P. J., & Birnbaum, M. J. (2008) · Oncogene · doi:10.1038/onc.2008.25 · Cited by 540
New insights into the pathophysiology of dyslipidemia in type 2 diabetes
Taskinen, M.-R., & Borén, J. (2015) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2015.01.039 · Cited by 440
Metadata
- Authors
- Kamagate, A., Qu, S., Perdomo, G., Su, D., Kim, D. H., Slusher, S., Meseck, M., & Dong, H. H.
- Venue
- Journal of Clinical Investigation
- Published
- 2008-05-01
- Volume
- 118
- Issue
- 6
- Pages
- 2347-64
- ISSN
- 0021-9738 (ISSN-L)
- OpenAlex
- W2132961868
- Cited by
- 282
- References
- 80
- FWCI
- 9.93
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.